Clinical trial
The Effects of Risperidone and Olanzapine on Thinking
NCT00108368 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00108368 |
|---|---|
| Title | The Effects of Risperidone and Olanzapine on Thinking |
| Official title | The Cognitive Effects of Risperidone and Olanzapine |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Collaborators | Janssen, LP Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Psychotic Disorders |
| Intervention type | Drug |
| Interventions | Risperidone, Olanzapine |
| Start date | Oct 1, 2003 |
| Completion | Mar 1, 2006 |
| First posted | Apr 15, 2005 |
| Last update posted | Jan 21, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: